Cart
Orders
Not available hereProduct Overview
Juvéderm VOLITE is a cross-linked hyaluronic acid injectable gel containing lidocaine, manufactured by Allergan in France. The documented presentation contains two prefilled 1 mL syringes per box. For professional buyers comparing formulations, the principal specifications are hyaluronic acid at 12 mg/mL and the inclusion of lidocaine. The composition and packaging details below describe the documented manufacturer presentation; the destination-market label and exact supplied pack should be checked before procurement.
Key Features
- Cross-linked HA: Sterile hyaluronic acid gel of non-animal origin.
- Lidocaine-containing formulation: The Australian patient leaflet specifies lidocaine hydrochloride monohydrate at 3 mg per 1 mL syringe.
- Prefilled presentation: Two disposable 1 mL syringes per documented box.
Composition & Specifications
| Specification | Documented detail |
|---|---|
| Product | Juvéderm VOLITE |
| Manufacturer | Allergan, Pringy, Annecy, France |
| Country of origin | France |
| Formulation | Sterile, non-animal-origin, cross-linked hyaluronic acid injectable gel containing lidocaine |
| Hyaluronic acid | 12 mg/mL; 12 mg per 1 mL syringe |
| Lidocaine component | Lidocaine hydrochloride monohydrate 3 mg/mL, as specified in the Australian patient leaflet |
| Supporting formulation | Phosphate buffer, pH 7.2, sufficient to make 1 mL |
| Documented packaging | Two 1 mL prefilled syringes per box |
| Documented accessories | Four sterile, single-use 32G 1/2-inch needles in the Australian/New Zealand presentation |
Composition wording follows the Australian patient leaflet. The stated lidocaine amount refers to the named salt form, not lidocaine free base. Confirm the applicable label and included accessories for the supplied market presentation.
Storage & Handling
The Australian/New Zealand instructions specify storage between 2°C and 25°C and a two-year shelf life. Follow the supplied market-specific instructions and the expiry date printed on the package; the labeled shelf life does not indicate the remaining shelf life of any particular stock.
Frequently Asked Questions
What is Juvéderm VOLITE intended for?
The Australian/New Zealand manufacturer labeling describes filling superficial skin depressions, including fine lines, with additional improvement of hydration and elasticity. This is a market-specific labeled purpose, not a guarantee of outcomes or authorization in every country.
What should professional buyers confirm before procurement?
Confirm the manufacturer reference or UDI, destination-market labeling, pack contents and expiry date. The documented two-syringe presentation does not independently establish the exact packaging or accessories of a particular merchant lot.
Does Australian registration establish eligibility in other markets?
No. Juvéderm VOLITE is listed in Australia as a Class III medical device under ARTG entry 308188. That registration does not establish import, sale, advertising or purchasing permissions elsewhere. Applicable local requirements must be checked separately.